SCHEMBL93117

SCHEMBL93117

CCCCC=CCCCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.55
TRPV1 Q8NER1 2/20 0.55
TSHR P16473 3/20 0.53
ALDH1A1 P00352 1/20 0.53
F7 P08709 2/20 0.52
F3 P13726 2/20 0.52
LMNA P02545 2/20 0.46
TERT O14746 3/20 0.46
CYP1A2 P05177 2/20 0.46
MAPT P10636 2/20 0.46
CYP2C19 P33261 2/20 0.46
BLM P54132 2/20 0.46
HSD17B10 Q99714 2/20 0.46
FABP4 P15090 2/20 0.46
PTPN1 P18031 2/20 0.46
PPARG P37231 2/20 0.46
KMT2A Q03164 2/20 0.46
PPARD Q03181 2/20 0.46
PPARA Q07869 2/20 0.46
GMNN O75496 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23566850 1.00 FAAH (0.55) FAAHTRPV1TSHRALDH1A1F7
SCHEMBL9133779 1.00 FAAH (0.55) FAAHTRPV1TSHRALDH1A1F7
SCHEMBL93116 1.00 FAAH (0.55) FAAHTRPV1TSHRALDH1A1F7
SCHEMBL17262056 1.00 FAAH (0.55) FAAHTRPV1TSHRALDH1A1F7
SCHEMBL9133782 1.00 FAAH (0.55) FAAHTRPV1TSHRALDH1A1F7
Iodide SCHEMBL8717413 0.96 FAAH (0.52) FAAHTRPV1TSHRALDH1A1F7
SCHEMBL25214228 0.96 FAAH (0.52) FAAHTRPV1TSHRALDH1A1F7
SCHEMBL28033081 0.96 FAAH (0.60) FAAHTRPV1TSHRALDH1A1F7
SCHEMBL2851962 0.93 FAAH (0.65) FAAHTRPV1F7F3LMNA
Decane SCHEMBL11847893 0.93 FAAH (0.65) FAAHTRPV1TSHRF7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1060 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122070352-A Sustainable aviation fuel produced from normal alpha olefin byproducts and method thereof 切弗朗菲利浦化学公司 2026-05-19 CN claimed
US-20260130860-A1 LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS FLAGSHIP LABS 114, INC. (US) 2026-05-14 US claimed
CN-122010914-A Quinazoline-coumarin compound and preparation method and application thereof 郑州大学 2026-05-12 CN claimed
US-12618016-B2 Methods for producing aviation fuels CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2026-05-05 US claimed
US-20260103649-A1 SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME CHEVRON PHILLIPS CHEMICAL CO LP (US) 2026-04-16 US claimed
US-20260078078-A1 CONVERSION OF MUCONOLACTONE TO BETA-KETOADIPATES AND METHODS THEREFOR U.S. DEPARTMENT OF ENERGY 2026-03-19 US claimed
WO-2026043730-A1 METHODS FOR PRODUCING AVIATION FUELS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2026-02-26 WO claimed
US-20260049256-A1 METHODS FOR PRODUCING AVIATION FUELS CHEVRON PHILLIPS CHEMICAL COMPANY LP 2026-02-19 US claimed
EP-4687854-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY Flagship Labs 114, Inc. (US) 2026-02-11 EP claimed
US-12540287-B2 Sustainable aviation fuel from normal alpha olefin byproducts and process for same CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2026-02-03 US claimed
EP-1413610-A1 Nonionic additives to control puddling in inkjet inks Hewlett-Packard Development Company, L.P. (US) 2004-04-28 EP claimed
US-20040055506-A1 Nonionic additives to control puddling in inkjet inks HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2004-03-25 US claimed
US-6410497-B1 DETERGENTS; BLEACHES; ANTISEPTICS BASF AKTIENGESELLSCHAFT (DE) 2002-06-25 US claimed
US-5837146-A HOMOGENOUS THERMAL REACTION PRODUCT OF AN ALKYL(METH)ACRYLATE (CO)POLYMER MODIFIED WITH UNSATURATED OIL COMPONENT SUCH AS GLYCERIDE, FATTY ACID, ALKENE, AND/OR ALKYNE; FOR CLEANING ENVIRONMENTAL OIL SPILLS ON WATER MANSFIELD & ALPER, INC. (US) 1998-11-17 US claimed
EP-0871593-A1 OIL COAGULANT PRODUCTS AND METHODS OF USE THEREFOR Mansfield & Alper, Inc. (US) 1998-10-21 EP claimed
US-5726856-A Hexasubstituted guanidinium salts and ultracapacitors employing them as electrolytes GENERAL ELECTRIC COMPANY (US) 1998-03-10 US claimed
WO-1997022558-A1 OIL COAGULANT PRODUCTS AND METHODS OF USE THEREFOR MANSFIELD & ALPER, INC. (US) 1997-06-26 WO claimed
US-5614170-A CONTRAST AGENTS OF DIETHYLENETRIAMINEPENTAACETIC ACID CHELATE COMPOUNDS HEMAGEN/PFC (US) 1997-03-25 US claimed
WO-1995033494-A1 EMULSIONS OF PARAMAGNETIC CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING (MRI), CONTAINING AN ORGANIC CHELATOR HAVING AN UNSATURATED ALIPHATIC GROUP HEMAGEN/PFC (US) 1995-12-14 WO claimed
WO-1995028146-A1 FLUOROCHEMICAL EMULSIONS CONTAINING 1,3-DIALKYLGLYCEROPHOSPHORYL CHOLINE SURFACTANTS AND METHODS OF USE HEMAGEN/PFC (US) 1995-10-26 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12618016-B2 Methods for producing aviation fuels CYP4F8, CYP8B1, CYP2E1 FAAH 978/4885TRPV1 4329/4885TSHR 4270/4885
US-20260103649-A1 SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME YAP1, CYP4F8, SCD FAAH 2017/4885TRPV1 3362/4885TSHR 4325/4885
US-20260078078-A1 CONVERSION OF MUCONOLACTONE TO BETA-KETOADIPATES AND METHODS THEREFOR PRKCD, PRKCZ, KHK FAAH 905/4885TRPV1 3445/4885TSHR 2889/4885
US-20260049256-A1 METHODS FOR PRODUCING AVIATION FUELS CYP4F8, CPT1A, CBR1 FAAH 1617/4885TRPV1 4405/4885TSHR 4431/4885
US-12540287-B2 Sustainable aviation fuel from normal alpha olefin byproducts and process for same ADH1A, ADH1C, YAP1 FAAH 1482/4885TRPV1 4433/4885TSHR 3824/4885
US-20260130860-A1 LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS NSUN3, NSUN2, LDLR FAAH 3270/4885TRPV1 3541/4885TSHR 545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.